Switch to Miriam Rosin's research page...

2007

1. Poh CF, Ng SP, Williams PM, Zhang L, Laronde DM, Lane P, Macaulay C, Rosin MP. Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck. 29(1):71-6. (2007).
    [View Abstract - PubMed 16983693]  Request Paper

2. Rosin MP, Poh CF, Guillard M, Williams PM, Zhang L, MacaUlay C. Visualization and other emerging technologies as change makers for oral cancer prevention. Ann N Y Acad Sci. 1098:167-83. Epub 2007 Mar 1. (2007).
    [View Abstract - PubMed 17332080]  Request Paper

2006

3. Lane PM, Gilhuly T, Whitehead P, Zeng H, Poh CF, Ng S, Williams PM, Zhang L, Rosin MP, MacAulay CE. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt. 11(2):024006. (2006).
    [View Abstract - PubMed 16674196]  Request Paper

4. Poh CF, Zhang L, Anderson DW, Durham JS, Williams PM, Priddy RW, Berean KW, Ng S, Tseng OL, MacAulay C, Rosin MP. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res. 12(22):6716-22. (2006).
    [View Abstract - PubMed 17121891]  Request Paper

2005

5. Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL. Multiple microalterations detected at high frequency in oral cancer. Cancer Res. 65(17):7561-7. (2005).
    [View Abstract - PubMed 16140918]  Request Paper

6. Garnis C, Rosin MP, Zhang L, Lam WL. Alteration of AKAP220, an upstream component of the Rb pathway, in oral carcinogenesis. Int J Cancer. 116(5):813-9. (2005).
    [View Abstract - PubMed 15849745]  Request Paper

7. Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, Nakamura H, Berean K, Hovan A, Le ND, Hislop G, Priddy R, Hay J, Lam WL, Rosin MP. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res. 65(17):8017-21. (2005).
    [View Abstract - PubMed 16140975]  Request Paper

2004

8. Garnis C, Campbell J, Zhang L, Rosin MP, Lam WL. OCGR array: an oral cancer genomic regional array for comparative genomic hybridization analysis. Oral Oncol 40(5):511-9. (2004).
    [View Abstract - PubMed 15006624]  Request Paper

9. Garnis C, Coe BP, Ishkanian A, Zhang L, Rosin MP, Lam WL. Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer. Genes Chromosomes Cancer 39(1):93-8. (2004).
    [View Abstract - PubMed 14603447]  Request Paper

10. Garnis C, Coe BP, Zhang L, Rosin MP, Lam WL. Overexpression of LRP12, a gene contained within an 8q22 amplicon identified by high-resolution array CGH analysis of oral squamous cell carcinomas. Oncogene 23(14):2582-6. (2004).
     [View Abstract - PubMed 14676824]  Request Paper

2003

11. Epstein JB, Zhang L, Poh C, Nakamura H, Berean K, Rosin M. Increased allelic loss in toluidine blue-positive oral premalignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95(1):45-50. (2003).
     [View Abstract - PubMed 12539026]  Request Paper

12. Garnis C, Baldwin C, Zhang L, Rosin MP, Lam WL. Use of complete coverage array comparative genomic hybridization to define copy number alterations on chromosome 3p in oral squamous cell carcinomas. Cancer Res 63(24):8582-5. (2003).
     [View Abstract - PubMed 14695166]  Request Paper

2002

13. Al-Ghamdi A, Freedman D, Miller D, Poh C, Rosin M, Zhang L, Gilks CB. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol Oncol 84(1):94-101. (2002).
     [View Abstract - PubMed 11748983]  Request Paper

14. Epstein JB, Zhang L, Rosin M. Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 68(10):617-21. (2002).
     [View Abstract - PubMed 12410942]  Request Paper

15. Rosin MP, Lam WL, Poh C, Le ND, Li RJ, Zeng T, Priddy R, Zhang L. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res 62(22):6447-50. (2002).
     [View Abstract - PubMed 12438233]  Request Paper

16. Siwoski A, Ishkanian A, Garnis C, Zhang L, Rosin M, Lam WL. An efficient method for the assessment of DNA quality of archival microdissected specimens. Mod Pathol 15(8):889-92. (2002).
     [View Abstract - PubMed 12181275]  Request Paper

17. Zhang L, Epstein JB, Poh CF, Berean K, Lam WL, Zhang X, Rosin MP. Comparison of HPV infection, p53 mutation and allelic losses in post-transplant and non-posttransplant oral squamous cell carcinomas. J Oral Pathol Med 31(3):134-41. (2002).
     [View Abstract - PubMed 11903818]  Request Paper

2001

18. Poh CF, Zhang L, Lam WL, Zhang X, An D, Chau C, Priddy R, Epstein J, Rosin MP. A high frequency of allelic loss in oral verrucous lesions may explain malignant risk. Lab Invest 81(4):629-34. (2001).
     [View Abstract - PubMed 11304582]  Request Paper

19. Zhang L, Cheung KJ Jr, Lam WL, Cheng X, Poh C, Priddy R, Epstein J, Le ND, Rosin MP. Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer 91(11):2148-55. (2001).
     [View Abstract - PubMed 11391596]  Request Paper

20. Zhang L, Cheung KJ Jr, Lam WL, Cheng X, Poh C, Priddy R, Epstein J, Le ND, Rosin MP. Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer 91(11):2148-55. (2001).
     [View Abstract - PubMed 11391596]  Request Paper

21. Zhang L, Poh CF, Lam WL, Epstein JB, Cheng X, Zhang X, Priddy R, Lovas J, Le ND, Rosin MP. Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: molecular evidence of incomplete resection. Oral Oncol 37(6):505-12. (2001).
     [View Abstract - PubMed 11435177]  Request Paper

22. Zhang L, Rosin MP. Loss of heterozygosity: a potential tool in management of oral premalignant lesions? J Oral Pathol Med 30(9):513-20. (2001).
     [View Abstract - PubMed 11555152]  Request Paper

2000

23. Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, Berean K, Epstein JB, Priddy R, Le ND, Zhang L. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 6(2):357-62. (2000).
     [View Abstract - PubMed 10690511]  Request Paper

24. Zhang L, Cheng X, Li Y, Poh C, Zeng T, Priddy R, Lovas J, Freedman P, Daley T, Rosin MP. High frequency of allelic loss in dysplastic lichenoid lesions. Lab Invest 80(2):233-7. (2000).
     [View Abstract - PubMed 10701692]  Request Paper

1999

25. Zhang L, Epstein J, Band P, Berean K, Hay J, Cheng X, Rosin MP. Local tumor recurrence or emergence of a new primary lesion? A molecular analysis. J Oral Pathol Med 28(8):381-4. (1999).
     [View Abstract - PubMed 10478965]  Request Paper

1997

26. Hofseth, L.J., Tsang, S.S., and Rosin, M.P.. Rejoining of DNA double strand breaks after the introduction of chromosome 11 into a radiosensitive bladder carcinoma cell line. Mutat. Res. DNA Repair, 383:21-30 (1997).
     [View Abstract - PubMed 9042416]  Request Paper

27. Rosin MP, Epstein JB, Berean K, Durham S, Hay J, Cheng X, Zeng T, Huang Y, Zhang L. The use of exfoliative cell samples to map clonal genetic alterations in the oral epithelium of high-risk patients. Cancer Res 57(23):5258-60. (1997).
     [View Abstract - PubMed 9393745]  Request Paper

28. Zhang L, Michelsen C, Cheng X, Zeng T, Priddy R, Rosin MP. Molecular analysis of oral lichen planus. A premalignant lesion? Am J Pathol 151(2):323-7. (1997).
     [View Abstract - PubMed 9250145]  Request Paper

1996

29. Hofseth LJ, Dunn BP, Rosin MP. Micronucleus frequencies in urothelial cells of catheterized patients with chronic bladder inflammation. Mutat Res 352(1-2):65-72. (1996).
     [View Abstract - PubMed 8676918]  Request Paper

30. Rosin MP, Miller SJ, Schwab D, Westra WH, Sidransky D. Molecular analysis of effectiveness of Mohs' surgical technique. Lancet 347(9016):1692-3. (1996).
     [View Abstract - PubMed 8642979]  Request Paper

31. Siddoo-Atwal C, Haas AL, Rosin MP. Elevation of interferon beta-inducible proteins in ataxia telangiectasia cells. Cancer Res 56(3):443-7. (1996).
     [View Abstract - PubMed 8564949]  Request Paper

1995

32. Rosin MP, Cairns P, Epstein JI, Schoenberg MP, Sidransky D. Partial allelotype of carcinoma in situ of the human bladder. Cancer Res 55(22):5213-6. (1995).
     [View Abstract - PubMed 7585577]  Request Paper

1994

33. Kuttan, A., Zhang, L., Rosin, M., Bhaktan, G. and Priddy, R.. The value of epidermal growth factor receptor (EGFR) as a tumor marker for oral premalignant and malignant lesions. Int. J. Oncology, 5: 955-960 (1994).
     Request Paper

34. Zhang, L., Michelsen, C., Priddy, R., Cheng, X. Tzeng, T., and Rosin, M.P.. Molecular analysis of oral lichen planus: are these premalignant lesions? Am. J. Path., in press. (1994).
     Request Paper

2003

1. Rosin MP, Zhang L, Poh C. Molecular markers of oral premalignant lesion risk Head and Neck Cancer: Emerging Prospectives, JF Ensley, JS Gutkind, JR. Jacobs and SM Lippman, (eds), Academic Press, Calif., p.245-259 (2003).
    Request Paper

1998

2. Rosin MP, Hofseth L. . Schistosomiasis, bladder and colon cancer Microbes and Malignancy: Infection as a Cause of Cancer, J. Parsonnet (ed.), Oxford University Press, New York, pp. 313-345 (1998).
    Request Paper

2003

1. Rosin MP, Lam WL, Zhang L. Correspondence re: M.P. Rosin et al., 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites Cancer Res., 62, 6647-6450, 2002. Reply. Cancer Res., 63: 5168-5169 (2003).
    Request Paper

2002

2. Zhang L , Rosin MP. . Two sides of a prevention 'coin': adequate screening and better tools. Letter to the Editor. J. Oral Path. Med., 31(4): 249-50 (2002).
    Request Paper